Cargando…

Altered Ultrasonic Vocalization and Impaired Learning and Memory in Angelman Syndrome Mouse Model with a Large Maternal Deletion from Ube3a to Gabrb3

Angelman syndrome (AS) is a neurobehavioral disorder associated with mental retardation, absence of language development, characteristic electroencephalography (EEG) abnormalities and epilepsy, happy disposition, movement or balance disorders, and autistic behaviors. The molecular defects underlying...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Yong-hui, Pan, Yanzhen, Zhu, Li, Landa, Luis, Yoo, Jong, Spencer, Corinne, Lorenzo, Isabel, Brilliant, Murray, Noebels, Jeffrey, Beaudet, Arthur L.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924885/ https://www.ncbi.nlm.nih.gov/pubmed/20808828 http://dx.doi.org/10.1371/journal.pone.0012278

Ejemplares similares

Truncation of Ube3a-ATS Unsilences Paternal Ube3a and Ameliorates Behavioral Defects in the Angelman Syndrome Mouse Model
por: Meng, Linyan, et al.
Publicado: (2013)

Excessive Laughter-like Vocalizations, Microcephaly, and Translational Outcomes in the Ube3a Deletion Rat Model of Angelman Syndrome
por: Berg, Elizabeth L., et al.
Publicado: (2021)

Deleting a UBE3A substrate rescues impaired hippocampal physiology and learning in Angelman syndrome mice
por: Sell, Gabrielle L., et al.
Publicado: (2021)

Strain-dependence of the Angelman Syndrome phenotypes in Ube3a maternal deficiency mice
por: Born, Heather A., et al.
Publicado: (2017)

From UBE3A to Angelman syndrome: a substrate perspective
por: Sell, Gabrielle L., et al.
Publicado: (2015)

Generation and Characterization of a Novel Angelman Syndrome Mouse Model with a Full Deletion of the Ube3a Gene
por: Syding, Linn Amanda, et al.
Publicado: (2022)

UBE3A reinstatement as a disease‐modifying therapy for Angelman syndrome
por: Elgersma, Ype, et al.
Publicado: (2021)

Loss of nuclear UBE3A activity is the predominant cause of Angelman syndrome in individuals carrying UBE3A missense mutations
por: Bossuyt, Stijn N V, et al.
Publicado: (2021)

Early Origin and Evolution of the Angelman Syndrome Ubiquitin Ligase Gene Ube3a
por: Sato, Masaaki
Publicado: (2017)

Delayed loss of UBE3A reduces the expression of Angelman syndrome-associated phenotypes
por: Sonzogni, Monica, et al.
Publicado: (2019)

Novel intragenic deletions within the UBE3A gene in two unrelated patients with Angelman syndrome: case report and review of the literature
por: Aguilera, Cinthia, et al.
Publicado: (2017)

Angelman syndrome-derived neurons display late onset of paternal UBE3A silencing
por: Stanurova, Jana, et al.
Publicado: (2016)

Persistent neuronal Ube3a expression in the suprachiasmatic nucleus of Angelman syndrome model mice
por: Jones, Kelly A., et al.
Publicado: (2016)

Longitudinal EEG model detects antisense oligonucleotide treatment effect and increased UBE3A in Angelman syndrome
por: Spencer, Elizabeth R., et al.
Publicado: (2022)

Visualization of the spatial positioning of the SNRPN, UBE3A, and GABRB3 genes in the normal human nucleus by three-color 3D fluorescence in situ hybridization
por: Kawamura, Rie, et al.
Publicado: (2012)

Corrigendum: Angelman syndrome-derived neurons display late onset of paternal UBE3A silencing
por: Stanurova, Jana, et al.
Publicado: (2018)

Angelman Syndrome Protein Ube3a Regulates Synaptic Growth and Endocytosis by Inhibiting BMP Signaling in Drosophila
por: Li, Wenhua, et al.
Publicado: (2016)

Antisense oligonucleotide treatment rescues UBE3A expression and multiple phenotypes of an Angelman syndrome mouse model
por: Milazzo, Claudia, et al.
Publicado: (2021)

The role of whole exome sequencing in the UBE3A point mutation of Angelman Syndrome: A case report
por: Triono, Agung, et al.
Publicado: (2021)

Protein Delivery of an Artificial Transcription Factor Restores Widespread Ube3a Expression in an Angelman Syndrome Mouse Brain
por: Bailus, Barbara J, et al.
Publicado: (2016)

Assessing the requirements of prenatal UBE3A expression for rescue of behavioral phenotypes in a mouse model for Angelman syndrome
por: Sonzogni, Monica, et al.
Publicado: (2020)

Evaluation of a TrkB agonist on spatial and motor learning in the Ube3a mouse model of Angelman syndrome
por: Schultz, Maria N., et al.
Publicado: (2020)

Association Analysis of GABRB3 Promoter Variants with Heroin Dependence
por: Chen, Chia-Hsiang, et al.
Publicado: (2014)

Personalized medicine: Vinpocetine to reverse effects of GABRB3 mutation
por: Billakota, Santoshi, et al.
Publicado: (2019)

Phenotype Expression Variability in Children with GABRB3 Heterozygous Mutations
por: Khair, Abdulhafeez M., et al.
Publicado: (2021)

No Gain, Less Pain: GABRB3 Mutations in Epileptic Encephalopathy
por: Gallagher, Martin J.
Publicado: (2022)

Angelman Syndrome Protein UBE3A Interacts with Primary Microcephaly Protein ASPM, Localizes to Centrosomes and Regulates Chromosome Segregation
por: Singhmar, Pooja, et al.
Publicado: (2011)

Angelman syndrome-associated ubiquitin ligase UBE3A/E6AP mutants interfere with the proteolytic activity of the proteasome
por: Tomaić, V, et al.
Publicado: (2015)

PKA and Ube3a regulate SK2 channel trafficking to promote synaptic plasticity in hippocampus: Implications for Angelman Syndrome
por: Sun, Jiandong, et al.
Publicado: (2020)

Dual-isoform hUBE3A gene transfer improves behavioral and seizure outcomes in Angelman syndrome model mice
por: Judson, Matthew C., et al.
Publicado: (2021)

Maternal transmission of a rare GABRB3 signal peptide variant is associated with autism
por: Delahanty, Ryan J., et al.
Publicado: (2009)

The Autism and Angelman Syndrome Protein Ube3A/E6AP: The Gene, E3 Ligase Ubiquitination Targets and Neurobiological Functions
por: Khatri, Natasha, et al.
Publicado: (2019)

Secreted retrovirus-like GAG-domain-containing protein PEG10 is regulated by UBE3A and is involved in Angelman syndrome pathophysiology
por: Pandya, Nikhil J., et al.
Publicado: (2021)

Characterization and structure-activity relationships of indenoisoquinoline-derived topoisomerase I inhibitors in unsilencing the dormant Ube3a gene associated with Angelman syndrome
por: Lee, Hyeong-Min, et al.
Publicado: (2018)

A behavioral test battery for mouse models of Angelman syndrome: a powerful tool for testing drugs and novel Ube3a mutants
por: Sonzogni, Monica, et al.
Publicado: (2018)

Two siblings suffering from Angelman Syndrome with a novel c.1146T>G mutation in UBE3A: A case report
por: Liu, Can, et al.
Publicado: (2022)

Genetic analysis of GABRB3 as a candidate gene of autism spectrum disorders
por: Chen, Chia-Hsiang, et al.
Publicado: (2014)

Gain-of-function GABRB3 variants identified in vigabatrin-hypersensitive epileptic encephalopathies
por: Absalom, Nathan L, et al.
Publicado: (2020)

Vocal coselection in rat pup ultrasonic vocalizations
por: Spence, Heather R., et al.
Publicado: (2016)

Towards a therapy for Angelman syndrome by reduction of a long non-coding RNA
por: Meng, Linyan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_r3i6842qgm8pqhgp038gs70qki